Milestone® Pharmaceuticals (NASDAQ:MIST) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its New Drug Application (NDA) for CARDAMYST™ ...

The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.

Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a challenge for Milestone Pharmaceutical in its 22 years. Now the wait will ...

March 28 (Reuters) - Milestone Pharmaceuticals (MIST.O), opens new tab said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had ...

Milestone Pharmaceuticals Inc.’s heart rhythm-restoring calcium channel blocker for paroxysmal supraventricular tachycardia (PSVT) has yet another obstacle in its way. A complete response letter (CRL) ...

Forbes contributors publish independent expert analyses and insights. Nick Crain is an NBA reporter covering the OKC Thunder for Forbes.

MSC Cruises and Chantiers de l’Atlantique marked major milestones for three World Class ships on March 27 at the shipyard in Saint-Nazaire, France. The events included the delivery of the MSC World ...

With each new baseball season, there are always more milestones to look out for -- and 2025 is no exception to that rule. Here is a look at some major milestones on the horizon for 2025 and beyond, ...

The insulated bottle has Hydro Flask’s trusted double-wall design, capable of keeping contents hot or cold for up to seven hours. It slides right into tote bags, jacket pockets, or lunch boxes ...